Edwards Lifesciences Corp (NYSE: EW) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Mark Wilterding -- Investor Relations Michael A. Mussallem -- Chairman and
Edwards Lifesciences Corp (EW) Q3 2020 Earnings Call Transcript
Categories
Health Care
Align Technology Inc. (ALGN) Q3 2020 Earnings Call Transcript
Align Technology Inc (NASDAQ: ALGN) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Shirley Stacy -- Vice President - Finance, Corporate and
Abbott Laboratories (ABT) Q3 2020 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and
Biogen Inc. (BIIB) Q3 2020 Earnings Call Transcript
Biogen Inc. (NASDAQ: BIIB) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Joe Mara -- Head of Investor Relations Michel Vounatsos -- Chief Executive Officer
Thermo Fisher Scientific Inc (TMO) Q3 2020 Earnings Call Transcript
Thermo Fisher Scientific Inc (NYSE: TMO) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Kenneth J. Apicerno -- Vice President, Investor Relations
ABT Earnings: Key numbers from Abbott Laboratories Q3 financial results
Abbott (NYSE: ABT) today announced its third quarter financial results for the period ended September 30, 2020. Net earnings for the third
Biogen tops market estimates in Q3, lowers guidance
Biogen (NASDAQ: BIIB) reported third-quarter 2020 financial results before the opening bell on Wednesday. The biotechnology giant reported a 6% decline in
Thermo Fisher Scientific (TMO) Earnings: 3Q20 Key Numbers
Thermo Fisher Scientific Inc. (NYSE: TMO) reported third quarter 2020 earnings results today. Revenue increased 36% year-over-year to $8.52 billion. GAAP earnings
IQVIA Holdings Inc. (IQV) Q3 2020 Earnings Call Transcript
IQVIA Holdings Inc. (NYSE: IQV) Q3 2020 earnings call dated Oct. 20, 2020 Corporate Participants: Andrew Markwick -- Senior Vice President, Investor Relations and
Walgreens Boots Alliance Inc. (WBA) Q4 2020 Earnings Conference Call
Listen to Walgreens Boots Alliance Inc. (WBA) Q4 2020 earnings conference call dated Oct. 15, 2020 Corporate Participants: Gerald Gradwell — Senior Vice President
Intuitive Surgical Inc. (ISRG) Q3 2020 Earnings Call Transcript
Intuitive Surgical Inc (NASDAQ: ISRG) Q3 2020 earnings call dated Oct. 15, 2020 Corporate Participants: Philip Kim -- Head of Investor Relations Gary S.
Theratechnologies Inc. (THTX) Q3 2020 Earnings Call Transcript
Theratechnologies Inc. (NASDAQ: THTX) Q3 2020 earnings call dated Oct. 15, 2020 Corporate Participants: Denis Boucher -- Vice President, Communications and Corporate Affairs Paul
Earnings: Intuitive Surgical (ISRG) Q3 results exceed estimates
Intuitive Surgical Inc. (NASDAQ: ISRG) reported lower earnings and revenues for the third quarter of 2020, hurt by the coronavirus-related disruption. However,
Walgreens Boots Alliance Inc. (WBA) Q4 2020 Earnings Call Transcript
Walgreens Boots Alliance Inc. (NASDAQ: WBA) Q4 2020 earnings call dated Oct. 15, 2020 Corporate Participants: Gerald Gradwell -- Senior Vice President of Special
UnitedHealth Group Inc. (UNH) Q3 2020 Earnings Call Transcript
UnitedHealth Group Inc. (NYSE: UNH) Q3 2020 earnings call dated Oct. 14, 2020 Corporate Participants: David S. Wichmann -- Chief Executive Officer John Rex -- Office
Key highlights from UnitedHealth Group (UNH) Q3 2020 earnings results
UnitedHealth Group Incorporated (NYSE: UNH) reported third quarter 2020 earnings results today. Revenues grew 8% to $65.1 billion year-over-year, helped by 21%
Johnson & Johnson (JNJ) Q3 2020 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q3 2020 earnings call dated Oct. 13, 2020 Corporate Participants: Christopher DelOrefice -- Vice President of Investor Relations Joseph
Johnson & Johnson (JNJ) Q3 earnings: Infographic
Johnson & Johnson (NYSE: JNJ) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported a 2%
AstraZeneca stock looks a good bet as COVID antibody drug brings fresh hope
With the pandemic situation showing little signs of improvement, healthcare institutions are under pressure to expedite their vaccine development programs, amid growing
OXFORD BIOMEDICA PLC (OXB) Q2 2020 Earnings Call Transcript
OXFORD BIOMEDICA PLC (OTC: OXB) Q2 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Catherine Isted -- Head of Corporate Development
Innate Pharma S.A. (IPHA) Q2 2020 Earnings Call Transcript
Innate Pharma S.A. (NASDAQ: IPHA) Q2 2020 earnings call dated Sep. 08, 2020. Corporate Participants: Mondher Mahjoubi -- Chairman of the Executive Board and